The Readout Loud

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(417)

Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype

Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype

Is Sarepta Therapeutics worth $10 billion? Will Theranos' Elizabeth Holmes go behind bars? And how does AI fit into biotech?

21 Jun 201825min

Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT

Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT

The problem with the topless dancers at PABNAB. Are investors overestimating the market for fatty liver drugs? And how many lives do biotech entrepreneurs get?

14 Jun 201823min

Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO

Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO

Why is Twitter so mean to Axovant? Adam teaches a crash course on biostatistics. And will sci-fi gene and cell therapies ever go mainstream.

7 Jun 201826min

Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?

Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?

Is the drug industry spending millions on a made-up disease? Have the latest cancer drugs been overhyped? And why does anyone go to BIO?

31 Mai 201822min

Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen

Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen

How worried should you be about Ebola? Can the government lower drug prices without hurting the drug industry? And is socceromics a thing? Listen this week to find out.

24 Mai 201827min

Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes

Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes

What do you call a unicorn without a horn? Is your colleague wearing a wire? And is Jentadueto a drug name or a complicated espresso drink?

17 Mai 201822min

Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?

Episode #10: Cohen, Trump, Novartis, oh my; Spark + Amish; Genetic testing at your doc's office?

On today's show, we dig into the no good, very bad day Novartis had when the world got wind of its ties to President Trump's personal attorney, a discussion of how the world's biggest cancer conferenc...

10 Mai 201822min

Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics

Episode #9 - Bill Gates on deadly flu, Chinese biotech bubbles, Golden State killer genetics

We talk to Bill Gates about the flu that could kill millions. Is China too enamored with biotech startups? And how do you find a cold case killer? Genetics.

3 Mai 201827min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
lydartikler-fra-aftenposten
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
pengepodden-2
rss-orjasater
utbytte
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
pengesnakk
stormkast-med-valebrokk-stordalen
lederpodden
morgenkaffen-med-finansavisen
liberal-halvtime
rss-markedspuls-2